Drugs & Targets FDA gives accelerated approval for Blincyto for ALL patients with minimal residual disease March 30, 2018Vol.44 No.13
Drugs & Targets Enfortumab vedotin gets breakthrough designation in urothelial cancer March 30, 2018Vol.44 No.13
Drugs & Targets FDA approves changes on Hologic’s 3Dimensions Mammography System March 30, 2018Vol.44 No.13
Drugs & Targets FDA accepts application for Opdivo plus Yervoy for MSI-H or dMMR metastatic colorectal cancer for priority review March 30, 2018Vol.44 No.13
Clinical Roundup Sorafenib improves PFS in rare sarcomas, NIH-funded study shows March 30, 2018Vol.44 No.13
Clinical Roundup Zejula plus Keytruda shows activity in refractory ovarian cancer March 30, 2018Vol.44 No.13
Clinical Roundup Retrospective analysis identifies predictors of dose modification for niraparib March 30, 2018Vol.44 No.13
Funding Opportunities DOD publishes funding opportunities for breast and prostate cancer programs March 30, 2018Vol.44 No.13
